Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer

NCT00209677 is registered in ClinicalTrials.gov with Hokkaido Gastrointestinal Cancer Study Group as lead sponsor.

NCT NCT00209677
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00209677 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer
Lead sponsor
Hokkaido Gastrointestinal Cancer Study Group
Phase
Phase 1/2
Overall status
Suspended
Start date
December 31, 2004
Completion date
December 31, 2007
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer